The tool, called PATHOMIQ-PRAD, analyzes medical images to identify prostate cancer and more accurately predict disease progression, according to a Sept. 23 news release from Mount Sinai.
Researchers reported on the tool’s findings in a study published Sept. 3 in European Urology.
The tool is designed to allow physicians to “identify those at higher risk of rapid disease progression and provide more timely, accurate predictions for earlier interventions and more targeted, personalized, treatment plans,” the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
